A new direct synthesis of ACPA and novel AMPA analogues

  • David J. Burkhart
  • , Brendan Twamley
  • , Nicholas R. Natale

Research output: Contribution to journalArticlepeer-review

18 Scopus citations

Abstract

A novel synthesis of the potent glutamate neurotransmitter agonist (RS)-2-amino-3-(3-carboxy-5-methyl-4-isoxazolyl) propionic acid (ACPA) provides access to numerous analogues as drug candidates for neurological disorders. The one-pot synthesis of an alpha amino phosphonate from aldehyde 4 was successful using ErCl3 as a catalyst. Molecular modeling of the new amino phosphonic acid with the (RS)-2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl) propionic acid (AMPA) receptor crystal structure suggests this should be an effective receptor binder.

Original languageEnglish
Pages (from-to)8415-8418
Number of pages4
JournalTetrahedron Letters
Volume42
Issue number48
DOIs
StatePublished - Nov 26 2001

Funding

Financial support of this research from the National Institute of Neurological Disorders and Stroke (Grant NS38444-01) is gratefully acknowledged. We thank Dr. Gary Knerr, Dr. Alex Blumenfeld, and Dr. Andrzej Paszczysnki for their spectroscopic contributions. We acknowledge Dr. Eric Gouaux for helpful discussions concerning the AMPA receptor ligand binding domain.

Funder number
NS38444-01

    Keywords

    • AMPA
    • Glutamate
    • Isoxazole

    Fingerprint

    Dive into the research topics of 'A new direct synthesis of ACPA and novel AMPA analogues'. Together they form a unique fingerprint.

    Cite this